Schedule 13G ownership disclosure

HEPION PHARMACEUTICALS INC

Security class unavailable · CUSIP: 426897104

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,728,604
Percent of class
5.9600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-018267
Form type
SC 13G
Filer
Hepion Pharmaceuticals, Inc.
CIK
CIK 1583771
Filed
Feb 10, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub